메뉴 건너뛰기




Volumn 82, Issue 2, 1997, Pages 473-478

Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1;

EID: 0031032244     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.2.473     Document Type: Article
Times cited : (144)

References (37)
  • 1
    • 0023008693 scopus 로고
    • Proglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing
    • Mojsov S, Heinrich G, Wilson IB, Ravazzola M, Orci L, Habener JF. 1986 Proglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem. 261:11880-11889.
    • (1986) J Biol Chem , vol.261 , pp. 11880-11889
    • Mojsov, S.1    Heinrich, G.2    Wilson, I.B.3    Ravazzola, M.4    Orci, L.5    Habener, J.F.6
  • 2
    • 0023638829 scopus 로고
    • Glucagon-like peptide-1 7-36: A physiological incretin in man
    • Kreymann B, Williams G, Ghatei MA, Bloom SR. 1987 Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet. 2:1300-1303.
    • (1987) Lancet , vol.2 , pp. 1300-1303
    • Kreymann, B.1    Williams, G.2    Ghatei, M.A.3    Bloom, S.R.4
  • 3
    • 0026659679 scopus 로고
    • Glucagon-like peptide-1, a new hormone of the entero-insular axis
    • Ørskov C. 1992 Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia. 35:701-711.
    • (1992) Diabetologia , vol.35 , pp. 701-711
    • Ørskov, C.1
  • 4
    • 0029043139 scopus 로고
    • Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide
    • Fehmann HC, Göke R, Göke B. 1995 Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr Rev. 16:390-410.
    • (1995) Endocr Rev , vol.16 , pp. 390-410
    • Fehmann, H.C.1    Göke, R.2    Göke, B.3
  • 5
    • 0023104829 scopus 로고
    • Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut
    • Holst JJ, Ørskov C, Schwartz TW, Nielsen OV. 1987 Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett. 211:169-174.
    • (1987) FEBS Lett , vol.211 , pp. 169-174
    • Holst, J.J.1    Ørskov, C.2    Schwartz, T.W.3    Nielsen, O.V.4
  • 6
    • 0026080393 scopus 로고
    • (7-36)amide: Influences on basal and stimulated insulin and glucagon secretion in the mouse
    • (7-36)amide: influences on basal and stimulated insulin and glucagon secretion in the mouse. Pancreas. 6:208-215.
    • (1991) Pancreas , vol.6 , pp. 208-215
    • Fridolf, T.1    Böttcher, G.2    Sundler, F.3    Ahrén, B.4
  • 7
    • 0026596851 scopus 로고
    • Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus
    • Gutniak MK, Ørskov C, Holst JJ, Ahrén B, Efendic S. 1992 Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med. 326:1316-1322.
    • (1992) N Engl J Med , vol.326 , pp. 1316-1322
    • Gutniak, M.K.1    Ørskov, C.2    Holst, J.J.3    Ahrén, B.4    Efendic, S.5
  • 8
    • 0026542396 scopus 로고
    • Insulinotropic action of glucagon-like peptide-1-(7-37) in diabetic and nondiabetic subjects
    • Nathan DM, Schreiber E, Mojsov S, Habener JF. 1992 Insulinotropic action of glucagon-like peptide-1-(7-37) in diabetic and nondiabetic subjects. Diabetes Care. 15:270-276.
    • (1992) Diabetes Care , vol.15 , pp. 270-276
    • Nathan, D.M.1    Schreiber, E.2    Mojsov, S.3    Habener, J.F.4
  • 9
    • 0028296643 scopus 로고
    • Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal
    • D'Alessio DA, Kahn SE, Leusner CR, Ensinck JW. 1994 Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. J Clin Invest. 93:2263-2266.
    • (1994) J Clin Invest , vol.93 , pp. 2263-2266
    • D'Alessio, D.A.1    Kahn, S.E.2    Leusner, C.R.3    Ensinck, J.W.4
  • 10
    • 0028224617 scopus 로고
    • The insulinotropic actions of glucose-dependent insulinotyropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects
    • Elahi D, McAloon-Dyke M, Fukagawa NK, et al. 1994 The insulinotropic actions of glucose-dependent insulinotyropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects. Regul Pept. 51:63-74.
    • (1994) Regul Pept , vol.51 , pp. 63-74
    • Elahi, D.1    McAloon-Dyke, M.2    Fukagawa, N.K.3
  • 11
    • 0028930130 scopus 로고
    • Insulinotropic action of truncated glucagon-like peptide-1 in mice
    • Ahrén B. 1995 Insulinotropic action of truncated glucagon-like peptide-1 in mice. Acta Physiol Scand. 153:205-206.
    • (1995) Acta Physiol Scand , vol.153 , pp. 205-206
    • Ahrén, B.1
  • 12
    • 0028904931 scopus 로고
    • Insulinotropic actions of intravenous glucagon-like peptide-1 (7-36) [7-36 amide] in the fasting state in healthy subjects
    • Qualmann C, Nauck MA, Holst JJ, Ørskov C, Creutzfeldt W. 1995 Insulinotropic actions of intravenous glucagon-like peptide-1 (7-36) [7-36 amide] in the fasting state in healthy subjects. Acta Diabetol. 32:13-16.
    • (1995) Acta Diabetol , vol.32 , pp. 13-16
    • Qualmann, C.1    Nauck, M.A.2    Holst, J.J.3    Ørskov, C.4    Creutzfeldt, W.5
  • 13
    • 0029552470 scopus 로고
    • Glucose-dependent action of glucagon-like peptide-1 (7-37) in vivo during short or long-term administration
    • Hargrove DM, Nardone NA, Persson LM, Parker JC, Stevenson RW. 1995 Glucose-dependent action of glucagon-like peptide-1 (7-37) in vivo during short or long-term administration. Metabolism. 44:1231-1237.
    • (1995) Metabolism , vol.44 , pp. 1231-1237
    • Hargrove, D.M.1    Nardone, N.A.2    Persson, L.M.3    Parker, J.C.4    Stevenson, R.W.5
  • 14
    • 0028071448 scopus 로고
    • Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM
    • Gutniak MK, Linde B, Holst JJ, Efendic S. 1994 Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM. Diabetes Care. 17:1039-1044.
    • (1994) Diabetes Care , vol.17 , pp. 1039-1044
    • Gutniak, M.K.1    Linde, B.2    Holst, J.J.3    Efendic, S.4
  • 15
    • 0027248866 scopus 로고
    • Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients
    • Nauck MA, Kleine N, Ørskov C, Holst JJ, Willms B, Creutzfeldt W. 1993 Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 36:741-744.
    • (1993) Diabetologia , vol.36 , pp. 741-744
    • Nauck, M.A.1    Kleine, N.2    Ørskov, C.3    Holst, J.J.4    Willms, B.5    Creutzfeldt, W.6
  • 16
    • 0030068620 scopus 로고    scopus 로고
    • Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: Effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients
    • Willms B, Werner J, Holst JJ, Ørskov C, Creutzfeldt W, Nauck MA. 1996 Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients. J Clin Endocrinol Metab. 81:327-332.
    • (1996) J Clin Endocrinol Metab , vol.81 , pp. 327-332
    • Willms, B.1    Werner, J.2    Holst, J.J.3    Ørskov, C.4    Creutzfeldt, W.5    Nauck, M.A.6
  • 17
    • 0026110135 scopus 로고
    • B cells in type 2 diabetes mellitus
    • Porte, Jr, D. 1991 B cells in type 2 diabetes mellitus. Diabetes. 40:166-180.
    • (1991) Diabetes , vol.40 , pp. 166-180
    • Porte Jr., D.1
  • 19
    • 0026793446 scopus 로고
    • Role of glucose and insulin resistance in development of type 2 diabetes mellitus: Results of a 25-year follow-up study
    • Martín BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. 1992 Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 2:925-929.
    • (1992) Lancet , vol.2 , pp. 925-929
    • Martín, B.C.1    Warram, J.H.2    Krolewski, A.S.3    Bergman, R.N.4    Soeldner, J.S.5    Kahn, C.R.6
  • 20
    • 0023924773 scopus 로고
    • Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians
    • Lillioja S, Mott DM, Howard BV, et al. 1988 Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med. 318:1217-1225.
    • (1988) N Engl J Med , vol.318 , pp. 1217-1225
    • Lillioja, S.1    Mott, D.M.2    Howard, B.V.3
  • 21
    • 0022450553 scopus 로고
    • Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes
    • O'Rahilly SP, Rudenski AS, Burnett MA, Nugent Z, Hosker JP, Darling P. 1986 Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes. Lancet. 2:360-364.
    • (1986) Lancet , vol.2 , pp. 360-364
    • O'Rahilly, S.P.1    Rudenski, A.S.2    Burnett, M.A.3    Nugent, Z.4    Hosker, J.P.5    Darling, P.6
  • 22
    • 0021815093 scopus 로고
    • Abnormal glucose modulation of islet A- and B-cell responses to arginine in non-insulin-dependent diabetes mellitus
    • Dimitriadis GD, Pekling GB, Gerich JE. 1985 Abnormal glucose modulation of islet A- and B-cell responses to arginine in non-insulin-dependent diabetes mellitus. Diabetes. 34:541-547.
    • (1985) Diabetes , vol.34 , pp. 541-547
    • Dimitriadis, G.D.1    Pekling, G.B.2    Gerich, J.E.3
  • 23
    • 0028880997 scopus 로고
    • Role of insulin resistance in the pathogenesis of NIDDM
    • Yki-Järvinen H. 1995 Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia. 38:1378-1388.
    • (1995) Diabetologia , vol.38 , pp. 1378-1388
    • Yki-Järvinen, H.1
  • 24
    • 0023589251 scopus 로고
    • Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics
    • Baron AD, Shaeffer L, Shragg P, Kolterman OG. 1987 Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Diabetes. 36:274-283.
    • (1987) Diabetes , vol.36 , pp. 274-283
    • Baron, A.D.1    Shaeffer, L.2    Shragg, P.3    Kolterman, O.G.4
  • 25
    • 0021751981 scopus 로고
    • Diminished B cell secretory capacity in patients with non-insulin-dependent diabetes mellitus
    • Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte, Jr, D. 1984 Diminished B cell secretory capacity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 74:1318-1328.
    • (1984) J Clin Invest , vol.74 , pp. 1318-1328
    • Ward, W.K.1    Bolgiano, D.C.2    McKnight, B.3    Halter, J.B.4    Porte Jr., D.5
  • 26
    • 0018520840 scopus 로고
    • Glucose clamp technique: A method for quantifying insulin secretion and resistance
    • DeFronzo RA, Tobin JD, Andres R. 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J Physiol. 237:E214-E223.
    • (1979) Am. J Physiol. , vol.237
    • DeFronzo, R.A.1    Tobin, J.D.2    Andres, R.3
  • 27
    • 0016767914 scopus 로고
    • Potentiation of insulin release by glucose in man
    • Cerasi E. 1975 Potentiation of insulin release by glucose in man. Acta Endocrinol. 79:511-534.
    • (1975) Acta Endocrinol , vol.79 , pp. 511-534
    • Cerasi, E.1
  • 28
    • 0019351275 scopus 로고
    • Time and dose dependencies for priming effect of glucose on insulin secretion
    • Grill V. 1981 Time and dose dependencies for priming effect of glucose on insulin secretion. Am J Physiol. 240:E24-E31.
    • (1981) Am J Physiol , vol.240
    • Grill, V.1
  • 29
    • 0028281773 scopus 로고
    • Production and secretion of amidated and glycine-extended glucagon-like peptide-1 (GLP-1) in man
    • Ørskov C, Rabenhøj L, Kofod H, Wettergren A, Holst JJ. 1994 Production and secretion of amidated and glycine-extended glucagon-like peptide-1 (GLP-1) in man. Diabetes. 43:535-539.
    • (1994) Diabetes , vol.43 , pp. 535-539
    • Ørskov, C.1    Rabenhøj, L.2    Kofod, H.3    Wettergren, A.4    Holst, J.J.5
  • 31
    • 0029060435 scopus 로고
    • Drugs on the horizon for treatment of type 2 diabetes
    • Rachman J, Turner RC. 1995 Drugs on the horizon for treatment of type 2 diabetes. Diabet Med. 12:467-478.
    • (1995) Diabet Med , vol.12 , pp. 467-478
    • Rachman, J.1    Turner, R.C.2
  • 32
    • 0027772917 scopus 로고
    • The incretin notion and its relevance to diabetes
    • Habener JF. 1993 The incretin notion and its relevance to diabetes. Endocrinol Metab Clin North Am. 22:775-794.
    • (1993) Endocrinol Metab Clin North Am , vol.22 , pp. 775-794
    • Habener, J.F.1
  • 33
    • 0029020729 scopus 로고
    • Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance
    • Larsson H, Berglund G, Ahrén B. 1995 Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance. J Clin Endocrinol Metab. 80:1778-1782.
    • (1995) J Clin Endocrinol Metab , vol.80 , pp. 1778-1782
    • Larsson, H.1    Berglund, G.2    Ahrén, B.3
  • 34
    • 0028156856 scopus 로고
    • Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man
    • Hvidberg A, Toft Nielsen M, Hilsted J, Ørskov C, Holst JJ. 1994 Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man. Metabolism. 43:104-108.
    • (1994) Metabolism , vol.43 , pp. 104-108
    • Hvidberg, A.1    Toft Nielsen, M.2    Hilsted, J.3    Ørskov, C.4    Holst, J.J.5
  • 35
    • 0019995650 scopus 로고
    • Hepatic and peripheral insulin resistance: A common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus
    • DeFronzo RA, Simonson D, Ferrannini E. 1982 Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 23:313-319.
    • (1982) Diabetologia , vol.23 , pp. 313-319
    • DeFronzo, R.A.1    Simonson, D.2    Ferrannini, E.3
  • 36
    • 0016582510 scopus 로고
    • Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood
    • Horwitz DL, Starr JI, Mako ME, et al. 1975 Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest. 55:1278-1283.
    • (1975) J Clin Invest , vol.55 , pp. 1278-1283
    • Horwitz, D.L.1    Starr, J.I.2    Mako, M.E.3
  • 37
    • 0023239175 scopus 로고
    • Insulin suppresses its own secretion in vivo
    • Argoud GM, Schade DS, Eaton RP. 1987 Insulin suppresses its own secretion in vivo. Diabetes. 36:959-962.
    • (1987) Diabetes , vol.36 , pp. 959-962
    • Argoud, G.M.1    Schade, D.S.2    Eaton, R.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.